These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8762006)

  • 1. Donor-specific transfusions enhance the immunosuppressive effects of single-dose cyclosporine A and CTLA4-Ig but do not result in long-term graft acceptance in a histoincompatible model of rat lung allograft rejection.
    Jordan SC; Matsumara Y; Zuo XJ; Marchevsky A; Linsley P; Matloff J
    Transpl Immunol; 1996 Mar; 4(1):33-7. PubMed ID: 8762006
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of acute lung allograft rejection in rat by CTLA4Ig.
    Shiraishi T; Yasunami Y; Takehara M; Uede T; Kawahara K; Shirakusa T
    Am J Transplant; 2002 Mar; 2(3):223-8. PubMed ID: 12096784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
    Kurlberg G; Haglind E; Schön K; Törnqvist H; Lycke N
    Scand J Immunol; 2000 Mar; 51(3):224-30. PubMed ID: 10736090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1997 Sep; 64(6):897-900. PubMed ID: 9326417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
    Fu F; Li W; Lu L; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1999; 31(1-2):453. PubMed ID: 10083185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of organ transplant rejection with low doses of CsA and CTLA4-Ig].
    Qian Y; Chen G; Huang J
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):150-2. PubMed ID: 11955404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A; Russell ME; Glysing-Jensen T; Willett TA; Sayegh MH
    Transplantation; 1997 Apr; 63(8):1053-8. PubMed ID: 9133464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4-Ig: a novel immunosuppressive agent.
    Najafian N; Sayegh MH
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2147-57. PubMed ID: 11060799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplant Proc; 1999; 31(1-2):1244. PubMed ID: 10083555
    [No Abstract]   [Full Text] [Related]  

  • 12. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats.
    Echizenya H; Yamashita K; Takehara M; Konishi K; Nomura M; Yanagida N; Kitagawa N; Kobayashi T; Furukawa H; Inobe M; Uede T; Todo S
    Transplant Proc; 2001; 33(1-2):183-4. PubMed ID: 11266771
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of corneal allografts by CTLA4-Ig.
    Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
    Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism of CTLA4-IG and anti-CD4 monoclonal antibody treatment in a rat kidney transplant model.
    Graser E; Risch K; Linsley PS; Hancock WW; Müller A; Brock J; Reinke P; Kupiec-Weglinski JW; Volk HD; Lehmann M
    Transplant Proc; 1997; 29(1-2):1307-9. PubMed ID: 9123319
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat.
    Perico N; Amuchastegui S; Bontempelli M; Remuzzi G
    Transplantation; 1996 May; 61(9):1320-2. PubMed ID: 8629290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.